ResearchWorks Archive

Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive

Show simple item record Steiner, Robert A. en_US Bremner, William J. en_US Bagatell, Carrie J. en_US 2008-10-17T20:42:35Z 2008-10-17T20:42:35Z 1991-09 en_US
dc.identifier.citation J Clin Endocrinol Metab. 1991 Sep;73(3):465-9 en_US
dc.description.abstract No effective hormonal contraceptive has yet been devised for men. Through their suppressive effect on gonadotropin secretion, GnRH antagonists inhibit both testosterone (T) production and spermatogenesis in animals. Long term administration of an antagonist alone would result in androgen deficiency; this would cause unacceptable physiological and behavioral sequellae in men. Therefore, androgen replacement must be included in any GnRH antagonist regimen used in human male contraception. We tested the hypothesis that the combination of a GnRH antagonist plus T would suppress spermatogenesis in the male primate to azoospermic levels while maintaining normal serum T levels. We examined the effects of the GnRH antagonist Deterelix [N-Ac-DNal(2)1-DpCl-Phe2-DTrp3-DhArg(Et2)6 -DAla10-GnRH], alone and with simultaneous T replacement, on sperm production and serum T levels in adult male monkeys (n = 22). After 12 weeks of daily sc antagonist injection, all animals that received antagonist alone (n = 5) and those that 750 micrograms/ antagonist plus T (n = 5) were azoospermic. After 16 weeks, four of five animals that received 250 micrograms/ antagonist plus T became azoospermic. Control animals (n = 7) received daily injections of vehicle; sperm counts increased somewhat during the study period in that group. Castrate range T levels were achieved in animals receiving antagonist alone. T levels in the groups that received T supplementation and in the control group were in the normal male range throughout the treatment period. Sperm counts returned to the pretreatment range in all animals during the recovery period. We conclude that the combination of a GnRH antagonist plus T can induce azoospermia reversibly in this nonhuman primates species, and that a similar combination may be an effective contraceptive regimen in men. The GnRH antagonist alone may be an effective treatment for androgen-dependent neoplasia. en_US
dc.language.iso en_US en_US
dc.publisher Endocrine Society en_US
dc.subject andrology en_US
dc.subject 5-alpha reductase inhibitors en_US
dc.subject klinefelter's syndrome en_US
dc.subject spermatogenesis en_US
dc.subject reifenstein's syndrome en_US
dc.subject colchicine en_US
dc.subject male contraception en_US
dc.subject.mesh Research Support, U.S. Gov't, Non-P.H.S. en_US
dc.subject.mesh Male en_US
dc.subject.mesh Spermatogenesis, drug effects en_US
dc.subject.mesh Testis, cytology, drug effects en_US
dc.subject.mesh Research Support, U.S. Gov't, P.H.S. en_US
dc.subject.mesh Contraceptive Agents, Male, pharmacology en_US
dc.subject.mesh Testosterone, blood, pharmacology en_US
dc.subject.mesh Spermatozoa, drug effects en_US
dc.subject.mesh Gonadorelin, analogs & derivatives, antagonists & inhibitors, pharmacology en_US
dc.subject.mesh Macaca fascicularis en_US
dc.subject.mesh Drug Therapy, Combination en_US
dc.subject.mesh Animals en_US
dc.subject.mesh Body Weight, drug effects en_US
dc.title Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive en_US
dc.type Article en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ResearchWorks

Advanced Search


My Account